<DOC>
	<DOCNO>NCT01299532</DOCNO>
	<brief_summary>This open , multi-center , non comparative study evaluate safety efficacy Macrolane VRF30 female breast . 71 subject receive initial treatment maximum 120 ml Macrolane VRF30 per breast . 22 patient receive re-injection ( max 120 ml/breast ) Macrolane nine month initial treatment . Patients follow 24 month last treatment .</brief_summary>
	<brief_title>Macrolane VRF30 Enhancement Shape Fullness Female Breast</brief_title>
	<detailed_description />
	<criteria>Patients 25 60 year small breast seek enhancement shape fullness breast Unreasonable expectation regard increase breast volume Any medical condition may interfere way .</criteria>
	<gender>Female</gender>
	<minimum_age>25 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>February 2011</verification_date>
</DOC>